omicSynth: an Open Multi-omic Community Resource for Identifying Druggable Targets across Neurodegenerative Diseases

Treatments for neurodegenerative disorders remain rare, although recent FDA approvals, such as Lecanemab and Aducanumab for Alzheimer’s Disease, highlight the importance of the underlying biological mechanisms in driving discovery and creating disease modifying therapies. The global population is ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarado, Chelsea X., Makarious, Mary B., Weller, Cory A., Vitale, Dan, Koretsky, Mathew J., Bandres-Ciga, Sara, Iwaki, Hirotaka, Levine, Kristin, Singleton, Andrew, Faghri, Faraz, Nalls, Mike A., Leonard, Hampton L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120805/
https://www.ncbi.nlm.nih.gov/pubmed/37090611
http://dx.doi.org/10.1101/2023.04.06.23288266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120805/
https://www.ncbi.nlm.nih.gov/pubmed/37090611
http://dx.doi.org/10.1101/2023.04.06.23288266

Ejemplares similares